Kavita M Babu

Summary

Publications

  1. ncbi Opioid receptors and legal highs: Salvia divinorum and Kratom
    Kavita M Babu
    Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    Clin Toxicol (Phila) 46:146-52. 2008
  2. ncbi Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)
    Edward W Boyer
    Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA
    Addiction 103:1048-50. 2008
  3. ncbi Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant
    Michael Ganetsky
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, WCC 2, Boston, MA 02215, USA
    J Med Toxicol 7:281-7. 2011

Collaborators

Detail Information

Publications3

  1. ncbi Opioid receptors and legal highs: Salvia divinorum and Kratom
    Kavita M Babu
    Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    Clin Toxicol (Phila) 46:146-52. 2008
    ..The purpose of this article is to familiarize toxicologists and poison control specialists with these emerging psychoactive dietary supplements...
  2. ncbi Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)
    Edward W Boyer
    Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA
    Addiction 103:1048-50. 2008
    ..Kratom (Mitragynia speciosa korth) is recognized increasingly as a remedy for opioid withdrawal by individuals who self-treat chronic pain...
  3. ncbi Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant
    Michael Ganetsky
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, WCC 2, Boston, MA 02215, USA
    J Med Toxicol 7:281-7. 2011
    ..We present an article that reviews the pharmacokinetics, clinical trial literature, and consensus guidelines regarding this novel oral anticoagulant...